An accumulating body of evidence dearly establishes that estradiol is a pot
ent neuroprotective and neurotrophic factor in the adult: it influences mem
ory and cognition, decreases the risk and delays the onset of neurological
diseases such as Alzheimer's disease, and attenuates the extent of cell dea
th that results from brain injuries such as cerebrovascular stroke and neur
otrauma. Thus, estradiol appears to act at two levels: 1) it decreases the
risk of disease or injury; and/or 2) it decreases the extent of injury incu
rred by suppressing the neurotoxic stimulus itself or increasing the resili
ence of the brain to a given injury. During the past century, the average l
ife span of women has increased dramatically, whereas the time of the menop
ause has remained essentially constant. Thus, more women will live a larger
fraction of their lives in a postmenopausal, hypoestrogenic state than eve
r before. Clearly, it is critical for us understand the circumstances under
which estradiol exerts protective actions and the cellular and molecular m
echanisms that underlie these novel, nonreproductive actions.